Skip to main content

Advertisement

Springer Nature Link
Log in

A possible role of myristoylated alanine-rich C kinase substrate in endocytic pathway of Alzheimer’s disease

豆蔻酰化的富丙氨酸的蛋白激酶C 的底物在阿尔茨海默病胞吞过程中的作用

  • Minireview
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

It is believed that amyloid-β peptide (Aβ) plays a central role in the pathogenesis of Alzheimer’s disease (AD). Thus, the process of amyloid precursor protein (APP) cleavage is a key event and has raised much attention in the field of AD research. It is proposed that APP, β- and γ-secretases are all located on the lipid raft, and the meeting of them is an indispensable step for Aβ generation. Endocytosis can lead to clustering of APP, β- and γ-secretases from separate smaller lipid rafts into a larger one. On the other hand, for myristoylated alanine-rich C kinase substrate (MARCKS), phosphorylation by protein kinase C (PKC) or interaction with Ca2+ can lead to its release from membrane into cytoplasm. This process induces the release of actins and phosphatidylinositol 4, 5-bisphosphate (PIP2), which are important factors for endocytosis. Thus, the present review proposes that MARCKS may be implicated in Aβ generation, by modulating free PIP2 level and actin movement, causing endocytosis.

摘要

β淀粉样蛋白(amyloid β, Aβ)在阿尔茨海默病(Alzheimer’s disease, AD)的发病过程中的重要作用已为人熟知。 淀粉样前体蛋白(amyloid precursor protein, APP)的水解过程也因此成为AD研究的重点。 APP、 β-和γ-分泌酶都位 于脂筏上, 三者的相遇是产生Aβ 的必要步骤, 而胞吞作用则能使分布在微小脂筏上的APP、 β-和γ-分泌酶集中 到较大的脂筏上。 另一方面, 豆蔻酰化的富丙氨酸的蛋白激酶C的底物(myristoylated alanine-rich C kinase substrate, MARCKS)被蛋白激酶C磷酸化或与钙离子作用后, 会离开细胞膜进入细胞质, 进而引起在胞吞作用中起重要作用 的肌动蛋白和4, 5-二磷酸肌醇(PIP2)的释放。 因此, 本文提出假说, 认为MARCKS通过调节自由态PIP2 的水平和 肌动蛋白的运动, 引发胞吞作用, 进而在Aβ 的产生过程中起重要作用。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
€32.70 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Finland)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature 2004, 430: 631–639.

    Article  PubMed  CAS  Google Scholar 

  2. Tanzi RE, Moir RD, Wagner SL. Clearance of Alzheimer’s Abeta peptide: the many roads to perdition. Neuron 2004, 43: 605–608.

    PubMed  CAS  Google Scholar 

  3. Poirier J. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer’s disease. Neurobiol Aging 2005, 26: 355–361.

    Article  PubMed  CAS  Google Scholar 

  4. Lambert JC, Amouyel P. Genetic heterogeneity of Alzheimer’s disease: Complexity and advances. Psychoneuroendocrinology 2007, 32: 62–70.

    Article  CAS  Google Scholar 

  5. Ralph AN, Paul MM, Anne MC. The neuronal endosomal-lysosomal system in Alzheimer’s disease. J Alzheimers Dis 2001, 3: 97–107.

    Google Scholar 

  6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993, 261: 921–923.

    Article  PubMed  CAS  Google Scholar 

  7. Blennow K, de Leon M, Zetterberg H. Alzheimer’s disease. Lancet 2007, 368: 387–403.

    Article  CAS  Google Scholar 

  8. Simons K, Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 2002, 110: 597–603.

    PubMed  CAS  Google Scholar 

  9. Simons M, Keller P, Dichgans J, Schulz JB. Cholesterol and Alzheimer’s disease: is there a link? Neurology 2001, 57: 1089–1093.

    PubMed  CAS  Google Scholar 

  10. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methy-glutaryl coenzyme A reductase inhibitors. Arch Neurol 2000, 57: 1439–1443.

    Article  PubMed  CAS  Google Scholar 

  11. Cataldo AM, Nixon RA. Endocytic pathway abnormalities precede amyloid-beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 2000, 157: 277–286.

    PubMed  CAS  Google Scholar 

  12. Cataldo AM, Barnett JL, Pieroni C, Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 1997, 17: 6142–6151.

    PubMed  CAS  Google Scholar 

  13. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, et al. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 2004, 25: 1263–1272.

    Article  PubMed  CAS  Google Scholar 

  14. Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992, 256: 184–185.

    Article  PubMed  CAS  Google Scholar 

  15. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416: 535–539.

    Article  PubMed  CAS  Google Scholar 

  16. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987, 325: 733–736.

    Article  PubMed  CAS  Google Scholar 

  17. Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer’s disease amyloid-beta peptides. J Biol Chem 2005, 280: 37377–37382.

    Article  PubMed  CAS  Google Scholar 

  18. Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature 2004, 430: 631–639.

    Article  PubMed  CAS  Google Scholar 

  19. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer’s disease β-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 2006, 103: 11172–11177.

    Article  PubMed  CAS  Google Scholar 

  20. Osawa S, Funamoto S, Nobuhara M, Wada-Kakuda S, Shimojo M, Yagishita S, et al. Phosphoinositides suppress gamma-secretase in both the detergent-soluble and -insoluble states. J Biol Chem 2008, 283: 19283–19292.

    Article  PubMed  CAS  Google Scholar 

  21. Kojro E, Gimpl G, Lammich S, Marz W, Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10. Proc Natl Acad Sci U S A 2001, 98: 5815–5820.

    Article  PubMed  CAS  Google Scholar 

  22. Robert E, Patrick K, Christian H, Christoph T, Kai S. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003, 160: 113–122.

    Article  CAS  Google Scholar 

  23. Smythe E, Ayscough KR. Actin regulation in endocytosis. J Cell Sci 2006, 119: 4589–4598.

    Article  PubMed  CAS  Google Scholar 

  24. Clague MJ. Molecular aspects of the endocytic pathway. Biochem J 1998, 336: 271–282.

    PubMed  CAS  Google Scholar 

  25. Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol 2004, 5: 121–132.

    Article  PubMed  CAS  Google Scholar 

  26. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Physiol Rev 1997, 77: 759–803.

    PubMed  CAS  Google Scholar 

  27. Soldati T, Schliwa M. Powering membrane traffic in endocytosis and recycling. Nat Rev Mol Cell Bio 2006, l7: 897–908.

    Article  CAS  Google Scholar 

  28. Zhang M. Endocytic mechanisms and drug discovery in neurodegenerative diseases. Front Biosci 2008, 13: 6086–6105.

    Article  PubMed  CAS  Google Scholar 

  29. Golde T, Estus S, Younkin L, Selkoe D, Younkin S. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 1992, 255: 728–730.

    Article  PubMed  CAS  Google Scholar 

  30. Perez RG, Soriano S, Hayes JD, Beth O, Weiming X, Dennis J, et al. Mutagenesis identifies new signals for β-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Aβ42. J Biol Chem 1999, 274: 18851–18856.

    Article  PubMed  CAS  Google Scholar 

  31. Koo EH, Squazzo SL. Evidence that production and release of amyloid β-protein involves the endocytic pathway. J Biol Chem 1994, 269: 17386–17389.

    PubMed  CAS  Google Scholar 

  32. Kai S, Robert E. Cholesterol, lipid rafts, and disease. J Clin Invest 2002, 110: 597–603.

    Google Scholar 

  33. Glaser M, Wanaski S, Buser CA, Boguslavsky V, Rashidzada W, Morris A, et al. Myristoylated alanine-rich C kinase Substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J Biol Chem 1996, 271: 26187–26193.

    Article  PubMed  CAS  Google Scholar 

  34. Arbuzova A, Schmitz AA, Vergeres G. Cross-talk unfolded: MARCKS proteins. Biochem J 2002, 362: 1–12.

    Article  PubMed  CAS  Google Scholar 

  35. McNamara RK, Hussain RJ, Simon EJ, Stumpo DJ, Blackshear PJ, Abel T, et al. Effect of myristoylated alanine-rich C kinase substrate (MARCKS) overexpression on hippocampus-dependent learning and hippocampal synaptic plasticity in MARCKS transgenic mice. Hippocampus 2005, 15: 675–683.

    Article  PubMed  CAS  Google Scholar 

  36. Laux T, Fukami K, Thelen M, Golub T, Frey D, Caroni P. GAP43, MARCKS, and CAP23 modulate PI(4,5)P2 at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol 2000, 149: 1455–1472.

    Article  PubMed  CAS  Google Scholar 

  37. Rheenen J, Achame EM, Janssen H, Calafat J, Jalink K. PIP2 signaling in lipid domains: a critical re-evaluation. EMBO J 2005, 24: 1664–1673.

    Article  PubMed  CAS  Google Scholar 

  38. Golub T, Caroni P. PI(4,5)P2-dependent microdomain assemblies capture microtubules to promote and control leading edge motility. J Cell Biol 2005, 169: 151–165.

    Article  PubMed  CAS  Google Scholar 

  39. Martin T. PI(4,5)P2 regulation of surface membrane traffic. Curr Opin Cell Biol 2001, 13: 493–499.

    Article  PubMed  CAS  Google Scholar 

  40. Pico Caroni. Actin cytoskeleton regulation through modulation of PI(4,5)P2 rafts. EMBO J 2001, 20: 4332–4336.

    Article  Google Scholar 

  41. Cremona O, De Camilli P. Phosphoinositides in membrane traffic at the synapse. J Cell Sci 2001, 114: 1041–1052.

    PubMed  CAS  Google Scholar 

  42. Botelho RJ, Dierckman R, Anderson R, Wells A, York JD, Meyer T, et al. Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol 2000, 151: 1353–1368.

    Article  PubMed  CAS  Google Scholar 

  43. Berman DE, Dall AC, Voronov SV, McIntire LB, Zhang H, Moore AZ, et al. Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat Neurosci 2008, 11: 547–554.

    Article  PubMed  CAS  Google Scholar 

  44. Landman N, Jeong SY, Shin SY, Voronov SV, Serban G, Kang MS, et al. Presenilin mutations linked to familial Alzheimer’s disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism. Proc Natl Acad Sci U S A 2006, 103: 19524–19529.

    Article  PubMed  CAS  Google Scholar 

  45. Coburn RF, Labelle EF, Baron CB. Polyamines, PI(4,5)P2, and actin polymerization. J Cell Physiol 2006, 209: 405–412.

    Article  PubMed  CAS  Google Scholar 

  46. Höning S, Ricotta D, Krauss M, Späte K, Spolaore B, Motley A, et al. Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adaptor complex AP2. Mol Cell 2005, 18: 519–531.

    Article  PubMed  CAS  Google Scholar 

  47. Lamaze C, Fujimoto LM, Yin HL, Schmid SL. The actin cytoskeleton is required for receptor-mediated endocytosis in mammalian cells. J Biol Chem 1997, 272: 20332–20335.

    Article  PubMed  CAS  Google Scholar 

  48. Jack Taunton. Actin filament nucleation by endosomes, lysosomes and secretory vesicles. Curr Opin Cell Biol 2001, 13: 85–91.

    Article  Google Scholar 

  49. Aderem A. The MARCKS brothers: a family of protein kinase C substrates. Cell 1992, 71: 713–716.

    Article  PubMed  CAS  Google Scholar 

  50. Blackshear PJ. The MARCKS family of cellular protein kinase C substrates. J Biol Chem 1993, 268: 1501–1504.

    PubMed  CAS  Google Scholar 

  51. Sundaram M, Cook HW, Byers DM. The MARCKS family of phospholipid binding proteins: regulation of phospholipase D and other cellular components. Biochem Cell Biol 2004, 82: 191–200.

    Article  PubMed  CAS  Google Scholar 

  52. Hartwig J, Thelen M, Rosen A, Janmey P, Nairn A, Aderem A. MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature 1992, 356: 618–622.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. China Academy of Chinese Medical Sciences, Beijing, 100700, China

    Rui Su  (苏芮) & Ji-Ping Fan  (范吉平)

  2. Beijing University of Traditional Chinese Medicine subsidiary Dongfang Hospital, Beijing, 100078, China

    Zhen-Yun Han  (韩振蕴) & Yun-Ling Zhang  (张允岭)

Authors
  1. Rui Su  (苏芮)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhen-Yun Han  (韩振蕴)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ji-Ping Fan  (范吉平)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yun-Ling Zhang  (张允岭)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhen-Yun Han  (韩振蕴).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Su, R., Han, ZY., Fan, JP. et al. A possible role of myristoylated alanine-rich C kinase substrate in endocytic pathway of Alzheimer’s disease. Neurosci. Bull. 26, 338–344 (2010). https://doi.org/10.1007/s12264-010-0131-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-010-0131-0

Keywords

关键词

Search

Navigation